Skip to main content

ADVERTISEMENT

Jolynn Tumolo

News
02/29/2024
Jolynn Tumolo
After hiring more than 61,000 employees in 2023, the Veterans Health Administration (VHA) is focusing on improving patient access even more by increasing worker productivity, Federal News Network recently reported.
After hiring more than 61,000 employees in 2023, the Veterans Health Administration (VHA) is focusing on improving patient access even more by increasing worker productivity, Federal News Network recently reported.
After hiring more than 61,000...
02/29/2024
Veterans Health Today
News
02/29/2024
Jolynn Tumolo
An incorrect expiration date on the product label has prompted the recall of 1099 vials of Adrenalin (epinephrine) injection packaged by Henry Schein Inc., according to the February 28, 2024, US Food and Drug Administration (FDA) Enforcement...
An incorrect expiration date on the product label has prompted the recall of 1099 vials of Adrenalin (epinephrine) injection packaged by Henry Schein Inc., according to the February 28, 2024, US Food and Drug Administration (FDA) Enforcement...
An incorrect expiration date on...
02/29/2024
Pharmacy Learning Network
News
02/29/2024
Jolynn Tumolo
More than 70,000 single-dose sachets of fosfomycin tromethamine granules for oral solution distributed by Ascend Laboratories are recalled after samples of the product tested out-of-specification for organic impurities.
More than 70,000 single-dose sachets of fosfomycin tromethamine granules for oral solution distributed by Ascend Laboratories are recalled after samples of the product tested out-of-specification for organic impurities.
More than 70,000 single-dose...
02/29/2024
Pharmacy Learning Network
News
02/29/2024
Jolynn Tumolo
A Class I recall has been issued for all Neptune’s Fix products because they contain tianeptine, an ingredient that is not approved for any medical use in the United States.
A Class I recall has been issued for all Neptune’s Fix products because they contain tianeptine, an ingredient that is not approved for any medical use in the United States.
A Class I recall has been issued...
02/29/2024
Pharmacy Learning Network
an illustration of a brain with a red spot in the center
News
02/27/2024
Jolynn Tumolo
In a pair of phase 3 trials, gantenerumab failed to ease clinical decline in patients with early Alzheimer disease compared with placebo. The medication did lower amyloid plaque burden, however.
In a pair of phase 3 trials, gantenerumab failed to ease clinical decline in patients with early Alzheimer disease compared with placebo. The medication did lower amyloid plaque burden, however.
In a pair of phase 3 trials,...
02/27/2024
Neurology
Neurologists examine brain scans
News
02/27/2024
Jolynn Tumolo
An unceasing stress response triggered by aggregated proteins may cause the death of brain cells in some neurodegenerative diseases, according to a paper published in the journal Nature.
An unceasing stress response triggered by aggregated proteins may cause the death of brain cells in some neurodegenerative diseases, according to a paper published in the journal Nature.
An unceasing stress response...
02/27/2024
Neurology
News
02/23/2024
Jolynn Tumolo
Two companies with multiple recalls in recent US Food and Drug Administration (FDA) Enforcement Reports received a combined 2 dozen FDA “observations” after October 2023 inspections of their India-based production plants.
Two companies with multiple recalls in recent US Food and Drug Administration (FDA) Enforcement Reports received a combined 2 dozen FDA “observations” after October 2023 inspections of their India-based production plants.
Two companies with multiple...
02/23/2024
Pharmacy Learning Network
News
02/23/2024
Jolynn Tumolo
Teva Pharmaceuticals USA Inc. is recalling two lots of Nortrel oral contraceptive products because of tablet discoloration issues. According to the February 21, 2024, US Food and Drug Administration (FDA) Enforcement Report, tablets in...
Teva Pharmaceuticals USA Inc. is recalling two lots of Nortrel oral contraceptive products because of tablet discoloration issues. According to the February 21, 2024, US Food and Drug Administration (FDA) Enforcement Report, tablets in...
Teva Pharmaceuticals USA Inc. is...
02/23/2024
Pharmacy Learning Network
News
02/23/2024
Jolynn Tumolo
While health insurance helps patients cover health care provider visits and prescription medications for managing medical conditions and illnesses, long-term care insurance can help patients access help with bathing, eating, and other...
While health insurance helps patients cover health care provider visits and prescription medications for managing medical conditions and illnesses, long-term care insurance can help patients access help with bathing, eating, and other...
While health insurance helps...
02/23/2024
Annals of Long-Term Care
News
02/22/2024
Jolynn Tumolo
A single lot of hydralazine hydrochloride tablets distributed by Major Pharmaceuticals is under recall following an out-of-specification result obtained during routine stability testing for impurities. The recall appeared in the February 21,...
A single lot of hydralazine hydrochloride tablets distributed by Major Pharmaceuticals is under recall following an out-of-specification result obtained during routine stability testing for impurities. The recall appeared in the February 21,...
A single lot of hydralazine...
02/22/2024
Pharmacy Learning Network